The features like portability, noteworthy benefits in the home healthcare applications, and ideal design that
enables dispense medication directly to the respiratory track are estimated to offer prospective growth
opportunities for its high utility. On the basis of drug type, the global Asthma Market size spans anti-
inflammatory, immunosuppressant, bronchodilators, mast cell stabilizers, leukotriene antagonists, and
combination of ICS/LABA. In this segmentation, the combination drug type consisting of inhaled corticosteroids
with long-acting beta agonists dominated the global Asthma Market in 2015.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/asthma-market
The factors that attribute to the large share of combination drug type are rise in application rates due to twofold
action of combination therapy and its high efficacy rate. On the basis of route of administration, the global
Asthma Market size spans inhaled, oral, intravenous, and subcutaneous. The inhaled route of administration
accounted for the largest market share of the Asthma Market in 2015. On the basis of geography, the global
Asthma Market size constitutes North America, Europe, Asia Pacific, and Rest of the World. North America holds
the largest share of the global Asthma Market due to rising number of asthma patients, increase in geriatric
population, drug innovation, high-tech advancement, and developed healthcare infrastructure.
The North American market is tracked by Europe. During the forecast period, the Asia Pacific’s market is
projected to witness a high growth rate owing to factors such as rise in population, increasing number of asthma
patients, emerging healthcare infrastructure and facilities, environmental pollution, growing disposable income,
and enlarging number of smokers. Some of the prominent players that fuel the growth of the Asthma Market
include AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion
Pharmaceuticals Inc., GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., GF Healthcare Products, Smith
Medicals, Lincare Holdings Inc., and Baxter International.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/healthcare